BTS issues new guideline on pleural mesothelioma

BTS issues new guideline on pleural mesothelioma

February 20 2018 New British Thoracic Society guidelines on pleural mesothelioma include some key...

EMA says no new patients should be started on Esyma for uterine fibroids

EMA says no new patients should be started on Esyma for uterine fibroids

February 13 2018 Doctors should not initiate Esyma (ulipristal acetate) in women with uterine...

New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

February 13 2018 The European Medicines Agency has issued new recommendations regarding use of...

EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

February 12 2018 The European Medicines Agency has updated recommendations regarding the use of...

New Drug Safety Updates issued for mycophenolate mofetil and misoprostol

New Drug Safety Updates issued for mycophenolate mofetil and misoprostol

February 9 2018 The medicines regulator has issued two Drug Safety Updates relating to...

  • BTS issues new guideline on pleural mesothelioma

    BTS issues new guideline on pleural mesothelioma

    Tuesday, 20 February 2018 17:21
  • EMA says no new patients should be started on Esyma for uterine fibroids

    EMA says no new patients should be started on Esyma for uterine fibroids

    Tuesday, 13 February 2018 12:44
  • New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

    New warnings issued for pregnancy and women using valproate for epilepsy, migraine, or bipolar

    Tuesday, 13 February 2018 12:40
  • EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

    EMA updates recommendations on avoidance of retinoids in pregnancy and effect on mental health

    Monday, 12 February 2018 14:44
  • New Drug Safety Updates issued for mycophenolate mofetil and misoprostol

    New Drug Safety Updates issued for mycophenolate mofetil and misoprostol

    Friday, 09 February 2018 15:24

welsh government logo cb 1August 1 2017
The Welsh Government has renewed its commitment to supporting people with neurological conditions by setting out its plans for 2017-2020.

 

 

 

 

 

Among the priorities highlighted in this latest plan are:

  • Raising awareness of neurological conditions by involving patients and carers in designing services
  • Ensuring timely diagnosis of neurological conditions by calling on Health Boards to provide specialist advice within 24 hours (on seven day week basis) for those admitted acutely to hospital with a suspected neurological problem
  • Making sure those living with a neurological condition have access to care and support as close to home as possible by a flexible workforce with the appropriate level of evidence based knowledge, skill and expertise.

Its new Neurological Conditions Delivery Plan updates the initial three year plan introduced in 2014. Among the progress made on original plan priorities in the three years to 2017 has been a reduction in the time patients with neurological conditions have needed to spend in secondary care:

  • the average time an individual spends in hospital fell from 6.4 days in 2010-11 to 4.2 days in 2015-16
  • the length of stay following an elective admission has reduced from 3.9 days to 2.2 days;
  • stays following emergency admissions fell from an average of 9.2 days to 7 days.

Health Secretary Vaughan Gething said: “We have already committed to investing £1.2m to improve access to neuro-rehabilitation services in Wales. The neurological conditions implementation group prioritises raising awareness of conditions, including the development of patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) to consistently improve the service.

“We want health boards to use this funding to make tangible differences in the health, wellbeing and independence of people living with long-term neurological conditions.”

Link:
Welsh Government announcement  

Clinical News

February 21 2018 Public Health Wales has published further information about the tendering process for GP software which has seen EMIS Health not able to continue as a supplier.
February 20 2018 New British Thoracic Society guidelines on pleural mesothelioma include some key recommendations for primary care. The BTS guideline give recommendations and good practice points...